Makes aortic stent grafts for patients with aortic disease.
Jun 2026Revenue $471M/yrExpenses $451M/yr
No trend
Figures by year
Is Artivion profitable?
Yes. In the 12 months to Jun 2026, revenue was $471M and expenses $451M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $441M | $408M | $33.7M |
| Dec 2024 | $389M | $350M | $38.9M |
| Dec 2023 | $354M | $348M | $5.74M |
| Dec 2022 | $314M | $308M | $6.20M |
| Dec 2021 | $299M | $291M | $8.12M |
| Dec 2020 | $253M | $251M | $2.44M |
| Dec 2019 | $276M | $259M | $17.0M |
| Dec 2018 | $263M | $254M | $9.31M |
| Dec 2017 | $190M | $182M | $7.97M |
| Dec 2016 | $180M | $159M | $21.8M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.